Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-000802-23Phase 2Active
Phase 2, open-label, single-arm trial of memantine in fibromyalgia (FM), sponsored by Javier GarcÃa Campayo. Primary endpoints: Change in brain glutamate levels and Change in pain intensity. Started Nov 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-000802-23.